Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Company / CIK 0000882796

BIOCRYST PHARMACEUTICALS INC

Ticker
BCRX
Size, estimated from filings
Mid cap ($2B – $10B)
Insiders on file
13
Members of Congress who traded it
1
Federal contracts on record
2 awards
Lobbying filings on record
none matched
SEC filings
EDGAR ↗
Latest trade on record
August 31, 2026

BIOCRYST PHARMACEUTICALS INC (BCRX) has 13 insiders on file who disclosed 83 transactions in the last 12 months (0 open-market buys, 17 sales, about $11.0M at reported prices), and 2 congressional trades in its stock are on record. USAspending shows 2 federal contract awards with a combined value of $182K to a recipient with this name that started in the last 180 days; no lobbying filing names it as client this year.

Last updated October 5, 2026 · Sources: SEC EDGAR; USAspending; Senate LDA

BIOCRYST PHARMACEUTICALS INC in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

7 people account for the disclosed buying and selling in BIOCRYST PHARMACEUTICALS INC over the last 12 months; the most active is Barnes Alane P with $3.7M.

Federal contracts by agency

Which agencies awarded BIOCRYST PHARMACEUTICALS INC contracts that started in the last 180 days?

Department of Veterans Affairs$182K
Department of Veter…$182K

Federal contract awards to BIOCRYST PHARMACEUTICALS INC that started in the last 180 days have a combined award value of $182K, most from Department of Veterans Affairs.

Insiders

NameRoleRowsBoughtSoldLast filed
Milne Jill C.Director800September 2, 2026
McKee Amy EDirector701September 2, 2026
Frank StevenDirector600September 2, 2026
MILANO VINCENTDirector600September 2, 2026
Stonehouse Jon PDirector1303September 2, 2026
HEGGIE THERESADirector501June 15, 2026
SANDERS MACHELLEDirector301June 15, 2026
LEVIN ALAN GDirector200June 15, 2026
Galson Steven KDirector200June 15, 2026
Barnes Alane PChief Legal Officer1709May 15, 2026
Menon SandeepChief R&D Officer200April 7, 2026
Gayer Charles KPresident and CCO1002December 23, 2025
Ghias BabarChief Financial Officer200December 19, 2025

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Members of Congress who traded BCRX

From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the BCRX page.

MemberSeatTradesBoughtSoldRange as filedLatest
Gilbert Ray Cisneros, Jr.Representative (CA, District 31), Democrat220$2,002–$30KJuly 10, 2026

Insider transactions

Download CSV85 rows · 30 KB · insider and congressional rows for this ticker · all downloads

FilerSecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Stonehouse Jon PBCRXOther AAugust 31, 2026September 2, 20262d644$10$6,247Form 4 ↗
Milne Jill C.BCRXOther AAugust 31, 2026September 2, 20262d1,288$10$12KForm 4 ↗
MILANO VINCENTBCRXOther AAugust 31, 2026September 2, 20262d1,159$10$11KForm 4 ↗
McKee Amy EBCRXOther AAugust 31, 2026September 2, 20262d644$10$6,247Form 4 ↗
Frank StevenBCRXOther AAugust 31, 2026September 2, 20262d1,288$10$12KForm 4 ↗
Milne Jill C.BCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
Milne Jill C.BCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
Galson Steven KBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
Galson Steven KBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
LEVIN ALAN GBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
LEVIN ALAN GBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
Frank StevenBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
Frank StevenBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
SANDERS MACHELLEBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
SANDERS MACHELLEBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
MILANO VINCENTBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
MILANO VINCENTBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
Stonehouse Jon PBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
Stonehouse Jon PBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
McKee Amy EBCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
McKee Amy EBCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
HEGGIE THERESABCRXOther AJune 11, 2026June 15, 20264d33,540——derivativeForm 4 ↗
HEGGIE THERESABCRXOther AJune 11, 2026June 15, 20264d15,294——Form 4 ↗
Milne Jill C.BCRXOther AMay 29, 2026June 2, 20264d1,262$9$11KForm 4 ↗
Stonehouse Jon PBCRXOther AMay 29, 2026June 2, 20264d631$9$5,622Form 4 ↗
McKee Amy EBCRXOther AMay 29, 2026June 2, 20264d631$9$5,622Form 4 ↗
MILANO VINCENTBCRXOther AMay 29, 2026June 2, 20264d1,122$9$9,997Form 4 ↗
Frank StevenBCRXOther AMay 29, 2026June 2, 20264d1,262$9$11KForm 4 ↗
McKee Amy EBCRXSell SMay 18, 2026May 19, 20261d11,180$9$100KForm 4 ↗
Barnes Alane PBCRXOption / conversion MMay 13, 2026May 15, 20262d62,500——10b5-1 planderivativeForm 4 ↗
Barnes Alane PBCRXSell SMay 13, 2026May 15, 20262d62,500$10$596K10b5-1 planForm 4 ↗
Barnes Alane PBCRXOption / conversion MMay 13, 2026May 15, 20262d62,500$5$315K10b5-1 planForm 4 ↗
Menon SandeepBCRXOther AApril 6, 2026April 7, 20261d441,350——derivativeForm 4 ↗
Menon SandeepBCRXOther AApril 6, 2026April 7, 20261d205,150——Form 4 ↗
HEGGIE THERESABCRXOption / conversion MMarch 20, 2026March 24, 20264d49,933——derivativeForm 4 ↗
HEGGIE THERESABCRXSell SMarch 20, 2026March 24, 20264d49,933$10$505KForm 4 ↗
HEGGIE THERESABCRXOption / conversion MMarch 20, 2026March 24, 20264d49,933$6$315KForm 4 ↗
Barnes Alane PBCRXOption / conversion MMarch 16, 2026March 18, 20262d150,000——10b5-1 planderivativeForm 4 ↗
Barnes Alane PBCRXSell SMarch 16, 2026March 18, 20262d150,000$9$1.4M10b5-1 planForm 4 ↗
Barnes Alane PBCRXOption / conversion MMarch 16, 2026March 18, 20262d150,000$6$827K10b5-1 planForm 4 ↗
Milne Jill C.BCRXOther AFebruary 27, 2026March 3, 20264d528$9$4,620Form 4 ↗
Stonehouse Jon PBCRXOption / conversion MMarch 2, 2026March 3, 20261d305,995——10b5-1 planderivativeForm 4 ↗
Stonehouse Jon PBCRXSell DMarch 2, 2026March 3, 20261d305,995$9$2.6M10b5-1 planForm 4 ↗
Stonehouse Jon PBCRXOption / conversion MMarch 2, 2026March 3, 20261d305,995$3$985K10b5-1 planForm 4 ↗
Stonehouse Jon PBCRXOther AFebruary 27, 2026March 3, 20264d421$9$3,68410b5-1 planForm 4 ↗
MILANO VINCENTBCRXOther AFebruary 27, 2026March 3, 20264d848$9$7,420Form 4 ↗
Frank StevenBCRXOther AFebruary 27, 2026March 3, 20264d1,285$9$11KForm 4 ↗
McKee Amy EBCRXOther AFebruary 27, 2026March 3, 20264d642$9$5,618Form 4 ↗
Milne Jill C.BCRXOther AJanuary 23, 2026January 27, 20264d26,684——derivativeForm 4 ↗
Milne Jill C.BCRXOther AJanuary 23, 2026January 27, 20264d12,272——Form 4 ↗
Milne Jill C.BCRXOther AJanuary 23, 2026January 27, 20264d2,582——Form 4 ↗
Stonehouse Jon PBCRXSell FDecember 19, 2025December 23, 20254d61,793$7$458KForm 4 ↗
Barnes Alane PBCRXSell SDecember 22, 2025December 23, 20251d21,773$8$167K10b5-1 planForm 4 ↗
Barnes Alane PBCRXSell FDecember 19, 2025December 23, 20254d16,902$7$125K10b5-1 planForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d50,000——derivativeForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d10,091——derivativeForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d14,142——derivativeForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d50,000$6$276KForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d10,091$5$51KForm 4 ↗
Gayer Charles KBCRXOption / conversion MDecember 22, 2025December 23, 20251d14,142$3$46KForm 4 ↗
Gayer Charles KBCRXSell FDecember 19, 2025December 23, 20254d11,477$7$85KForm 4 ↗
Stonehouse Jon PBCRXOther GDecember 18, 2025December 19, 20251d10,000——indirectForm 4 ↗
Stonehouse Jon PBCRXOther GDecember 18, 2025December 19, 20251d10,000——indirectForm 4 ↗
Stonehouse Jon PBCRXOther GDecember 18, 2025December 19, 20251d20,000——Form 4 ↗
Gayer Charles KBCRXOther ADecember 17, 2025December 19, 20252d986,950——derivativeForm 4 ↗
Gayer Charles KBCRXOther ADecember 17, 2025December 19, 20252d471,000——Form 4 ↗
Barnes Alane PBCRXOther ADecember 17, 2025December 19, 20252d255,050——derivativeForm 4 ↗
Barnes Alane PBCRXOther ADecember 17, 2025December 19, 20252d121,700——Form 4 ↗
Ghias BabarBCRXOther ADecember 17, 2025December 19, 20252d355,050——derivativeForm 4 ↗
Ghias BabarBCRXOther ADecember 17, 2025December 19, 20252d121,700——Form 4 ↗
Gayer Charles KBCRXSell FDecember 12, 2025December 16, 20254d8,181$8$62KForm 4 ↗
Barnes Alane PBCRXSell SDecember 15, 2025December 16, 20251d21,210$8$162K10b5-1 planForm 4 ↗
Barnes Alane PBCRXSell FDecember 12, 2025December 16, 20254d8,540$8$65K10b5-1 planForm 4 ↗
Stonehouse Jon PBCRXSell FDecember 12, 2025December 16, 20254d27,368$8$207KForm 4 ↗
Barnes Alane PBCRXOption / conversion MDecember 1, 2025December 3, 20252d91,004——10b5-1 planderivativeForm 4 ↗
Barnes Alane PBCRXSell SDecember 3, 2025December 3, 20250d19,770$8$151K10b5-1 planForm 4 ↗
Barnes Alane PBCRXSell SDecember 2, 2025December 3, 20251d50,906$7$367K10b5-1 planForm 4 ↗
Barnes Alane PBCRXSell SDecember 1, 2025December 3, 20252d91,004$7$647K10b5-1 planForm 4 ↗
Barnes Alane PBCRXOption / conversion MDecember 1, 2025December 3, 20252d91,004$3$293K10b5-1 planForm 4 ↗
McKee Amy EBCRXOther ANovember 28, 2025December 2, 20254d783$7$5,622Form 4 ↗
Frank StevenBCRXOther ANovember 28, 2025December 2, 20254d1,566$7$11KForm 4 ↗
MILANO VINCENTBCRXOther ANovember 28, 2025December 2, 20254d783$7$5,622Form 4 ↗
SANDERS MACHELLEBCRXSell SNovember 13, 2025November 17, 20254d9,600$7$69K10b5-1 planForm 4 ↗

Federal contracts (USAspending, awards started in the last 180 days)

Start dateAwarding agencyAward valueNAICSSource
May 19, 2026Department of Veterans Affairs$151,465325412USAspending ↗
May 21, 2026Department of Veterans Affairs$30,293325412USAspending ↗

Lobbying (Senate LDA, as client)

No LDA filing posted since October 2025 names "BIOCRYST PHARMACEUTICALS INC" as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.

Companies whose stock was traded by the same people who traded BCRX, by number of filers in common. It shows overlap in public filings and nothing else.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
House Clerk, periodic transaction reports22December 15, 2025September 4, 2026House Clerk search
SEC EDGAR, Form 44583November 17, 2025September 2, 2026Form 4 list on EDGAR
USAspending, federal contract awards2 awards———USAspending

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.